Novartis loses battle over Glivec

Swiss pharma major Novartis AG on Monday lost a seven-year long legal battle for getting its blood cancer drug Glivec patented in India and to restrain Indian companies from manufacturing generic drugs, with the Supreme Court rejecting the multinational company`s plea.

Apr 01, 2013, 17:21 PM IST